Letrozole Market Top Players, Segmentation & Future Trends Analysis till 2034
Letrozole is a non-steroidal aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. The drug works by lowering estrogen levels in the body, which can slow or stop the growth of certain types of breast cancer cells that require estrogen to grow. The Letrozole market is anticipated to reach USD xx billion by 2034, growing at a compound annual growth rate (CAGR) of xx based on average growth patterns. By 2024, the market is expected to be valued USD xx billion. The aging population, which raises the number of possible patients, and the rising prevalence of breast cancer, especially in postmenopausal women, are the main factors driving the worldwide letrozole market. Demand is further increased by developments in oncology and growing public awareness of early cancer detection. Growth in the market is further aided by the drug's off-label use in fertility treatments, especially for women with PCOS. Letrozole's acce...